BACKGROUND: Pertussis is a vaccine modified disease in most age groups and hence subtle in its presentation. Current diagnostic approaches require relatively invasive sampling. AIM: To determine the incidence of B. pertussis infection among people aged 5-49 years identified in primary care with acute persistent cough using an oral fluid based diagnostic test. DESIGN AND SETTING: Active surveillance of acute persistent cough of 2 weeks duration or greater was established in Auckland, New Zealand from May to October 2011. The 15 participating primary care practices provided care for a socioeconomically diverse population. METHOD: Recent B. pertussis infection was determined by measurement of IgG antibodies to pertussis toxin (PT) in an oral fluid sample. An IgG antibody titre to PT of ≥70 arbitrary units defined recent infection. Participants reported symptoms at presentation and kept a cough diary. RESULTS: A total of 226 participants were enrolled: 70 (31%) were children (5-16 years) and 156 (69%) were adults (17-49 years). Oral fluid samples were obtained from 225 participants. Ten per cent (23/225) had recent B. pertussis infection including a larger proportion of children than adults (17% versus 7%, P = 0.003). Neither cough duration nor any individual symptom discriminated between those with and without recent B. pertussis infection. CONCLUSION: Pertussis is a frequent cause of acute persistent cough presenting to primary care. Clinical differentiation of pertussis from other causes of acute persistent cough is difficult. An oral fluid based diagnostic test, which is less invasive than other diagnostic approaches, has high acceptability in primary care.
BACKGROUND: Pertussis is a vaccine modified disease in most age groups and hence subtle in its presentation. Current diagnostic approaches require relatively invasive sampling. AIM: To determine the incidence of B. pertussis infection among people aged 5-49 years identified in primary care with acute persistent cough using an oral fluid based diagnostic test. DESIGN AND SETTING: Active surveillance of acute persistent cough of 2 weeks duration or greater was established in Auckland, New Zealand from May to October 2011. The 15 participating primary care practices provided care for a socioeconomically diverse population. METHOD: Recent B. pertussis infection was determined by measurement of IgG antibodies to pertussis toxin (PT) in an oral fluid sample. An IgG antibody titre to PT of ≥70 arbitrary units defined recent infection. Participants reported symptoms at presentation and kept a cough diary. RESULTS: A total of 226 participants were enrolled: 70 (31%) were children (5-16 years) and 156 (69%) were adults (17-49 years). Oral fluid samples were obtained from 225 participants. Ten per cent (23/225) had recent B. pertussis infection including a larger proportion of children than adults (17% versus 7%, P = 0.003). Neither cough duration nor any individual symptom discriminated between those with and without recent B. pertussis infection. CONCLUSION: Pertussis is a frequent cause of acute persistent cough presenting to primary care. Clinical differentiation of pertussis from other causes of acute persistent cough is difficult. An oral fluid based diagnostic test, which is less invasive than other diagnostic approaches, has high acceptability in primary care.
Authors: H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens Journal: J Clin Microbiol Date: 2000-02 Impact factor: 5.948
Authors: K Stehr; J D Cherry; U Heininger; S Schmitt-Grohé; M uberall; S Laussucq; T Eckhardt; M Meyer; R Engelhardt; P Christenson Journal: Pediatrics Date: 1998-01 Impact factor: 7.124
Authors: Javier Diez-Domingo; Alfredo Ballester; José-María Baldó; María-Victoria Planelles; José V Villarroya; Trinidad Alvarez; M Carmen Peidró; Pura Calero; María D Garcés; Ignacio Sorribes; Marta Graullera; Angels Jubert; María San-Martín; Antonio González Journal: J Infect Date: 2004-10 Impact factor: 6.072
Authors: H E de Melker; J F Schellekens; S E Neppelenbroek; F R Mooi; H C Rümke; M A Conyn-van Spaendonck Journal: Emerg Infect Dis Date: 2000 Jul-Aug Impact factor: 6.883
Authors: Elizabeth Elliott; Peter McIntyre; Greta Ridley; Anne Morris; John Massie; Julie McEniery; Geoff Knight Journal: Pediatr Infect Dis J Date: 2004-03 Impact factor: 2.129
Authors: A Karagul; D Ogunc; K Midilli; G Ongut; B Ozhak Baysan; L Donmez; D Daglar; M A Kuskucu; A Bingol; O Ozbudak; D Colak; F Gunseren Journal: Epidemiol Infect Date: 2014-12-19 Impact factor: 4.434
Authors: Helen Campbell; Gayatri Amirthalingam; Norman K Fry; David Litt; Timothy G Harrison; Karen Wagner; Natasha S Crowcroft; Elizabeth Miller Journal: Emerg Infect Dis Date: 2014-06 Impact factor: 6.883
Authors: Jolien Teepe; Berna D L Broekhuizen; Margareta Ieven; Katherine Loens; Kris Huygen; Mirjam Kretzschmar; Hester de Melker; Chris C Butler; Paul Little; Beth Stuart; Samuel Coenen; Herman Goossens; Theo J M Verheij Journal: Br J Gen Pract Date: 2015-10 Impact factor: 5.386